Equities analysts predict that Acorda Therapeutics (NASDAQ:ACOR) will post sales of $124.79 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Acorda Therapeutics’ earnings. The highest sales estimate is $153.20 million and the lowest is $90.00 million. Acorda Therapeutics posted sales of $139.44 million in the same quarter […]